Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3792 3796
This examiner grants 22% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17293442 | HEALTH CARE PROVIDER AUTHORIZATION OF DATA ACQUISITION BY SENSOR ENABLED WOUND DRESSINGS AND DEVICES | Non-Final OA | Smith & Nephew PLC |
| 17744557 | SYSTEMS AND METHODS FOR OPTIMIZING NERVE STIMULATION | Final Rejection | ElectroCore, Inc. |
| 17036629 | BAILOUT MECHANISMS FOR SURGICAL TOOL | Non-Final OA | Cilag GmbH International |
| 16354420 | DUAL MODE CONTROLS FOR ROBOTIC SURGERY | Final Rejection | Cilag GmbH International |
| 17299869 | METHOD OF CONTROLLING CABLE DRIVEN END EFFECTORS | Non-Final OA | Covidien LP |
| 17159764 | SURGICAL SYSTEM INSTRUMENT MANIPULATOR | Non-Final OA | INTUITIVE SURGICAL OPERATIONS, INC. |
| 18391131 | CENTERING DEVICE FOR DETERMINING A CENTERING OF A VISUAL AXIS OF AN EYE | Non-Final OA | SCHWIND EYE-TECH-SOLUTIONS GMBH |
| 19075143 | NEURAL INTERFACE TECHNOLOGY FOR COMMUNICATING WITH CLINICALLY UNRESPONSIVE PATIENTS | Non-Final OA | PRECISION NEUROSCIENCE CORPORATION |
| 18472344 | INCONTINENCE THERAPY SCHEDULING | Non-Final OA | Medtronic, Inc. |
| 17663612 | BIOLOGICAL INFORMATION MANAGEMENT SYSTEM AND BIOLOGICAL INFORMATION MANAGEMENT METHOD | Final Rejection | OMRON HEALTHCARE Co., Ltd. |
| 18098057 | SYSTEMS, METHODS, AND MEDIA FOR PREDICTING A CONVERSION TIME OF MILD COGNITIVE IMPAIRMENT TO ALZHEIMER'S DISEASE IN PATIENTS | Non-Final OA | UNIVERSITY OF SOUTH FLORIDA |
| 18909837 | CROSS-APPENDAGE KINETIC STIMULATOR | Non-Final OA | The Q, LLC |
| 18163288 | CLOSED-LOOP NEUROSTIMULATION SYSTEM AND METHOD | Non-Final OA | City University of Hong Kong |
| 18753787 | Bolus Stimulation in a Neurostimulation Device Particularly Useful in Providing Sub-Perception Stimulation | Non-Final OA | Boston Scientific Neuromodulation Corporation |
| 16657560 | Varying Stimulation Parameters to Prevent Tissue Habituation in a Spinal Cord Stimulation System | Non-Final OA | Boston Scientific Neuromodulation Corporation |
| 17830998 | WMS-WCD HAVING UI WITH VOICE PROMPT TO RENEW BATTERY | Non-Final OA | West Affum Holdings DAC |
| 18651381 | SYSTEMS AND METHODS FOR DIAGNOSIS AND/OR TREATING DEMYELINATING NEUROPATHY | Non-Final OA | Rutgers, The State University of New Jersey |
| 17991810 | THERAPEUTIC MODULATION TO TREAT BLOOD GLUCOSE ABNORMALITIES, INCLUDING TYPE 2 DIABETES, AND/OR REDUCE HBA1C LEVELS, AND ASSOCIATED SYSTEMS AND METHODS | Non-Final OA | Nevro Corp. |
| 18582131 | DEVICE FOR MONITORING THE PSYCHOEMOTIONAL STATE OF A USER | Non-Final OA | Autism Care, LLC |
| 17292186 | NERVE REGENERATION THERAPY SYSTEM AND METHOD | Non-Final OA | CHECKPOINT SURGICAL, INC. |
| 18554505 | SYSTEMS AND METHODS FOR PREDICTING A CONDITION | Non-Final OA | Lindsay Lifescience LLC |
| 17870353 | ELECTRODE LOCATING SYSTEMS AND METHODS FOR USE DURING A COCHLEAR IMPLANT LEAD INSERTION PROCEDURE | Non-Final OA | Advanced Bionics AG |
| 17754966 | Sensor Determination | Non-Final OA | McLaren Applied Technologies Limited |
| 17764920 | NON-INVASIVE DETERMINATION OF GLUCOSE | Final Rejection | GLUCO TERA TECH AG |
| 17631210 | Systems and Methods For Movement Modulation of a Body Part of a Subject | Non-Final OA | UNIVERSITÉ DE MONTRÉAL |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy